-logo-1200x675.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
Summit Therapeutics (NASDAQ:SMMT) Stock Rating Lowered by StockNews.com
Summit Therapeutics (NASDAQ:SMMT – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday. Other research analysts also recently issued research reports about the stock. Wells Fargo & Company began coverage on shares of Summit Therapeutics in a research note on Wednesday, […]
Summit Therapeutics (NASDAQ:SMMT – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Tuesday. Other research analysts also recently issued research reports about the stock. Wells Fargo & Company began coverage on shares of Summit Therapeutics in a research note on Wednesday, […]
